Skip to main content
. 2019 Sep 4;4:21. doi: 10.1038/s41525-019-0095-6

Table 2.

CFTR variants found in 26 cases that underwent open chart review

Variant cDNA name Variant protein name CFTR2 (8/31/18) ClinVar Review Statusa ClinVar link (accessed 9/15/18) # alleles in compound heterozygous # alleles in homozygous # alleles
1 c.115 C > T p.Gln39Ter Q39X CF causing Pathogenic *3 https://www.ncbi.nlm.nih.gov/clinvar/23273455/ 1 0 1
2 c.263 T > G p.Leu88Ter L88X CF causing Pathogenic *3 https://www.ncbi.nlm.nih.gov/clinvar/variation/53534/ 1 0 1
3 c.350 G > A p.Arg117His R117H Varying clinical consequence Pathogenic *4 https://www.ncbi.nlm.nih.gov/clinvar/RCV000007528/ 1 0 1
4 c.489 + 1 G > T NA NA CF causing Pathogenic *4 https://www.ncbi.nlm.nih.gov/clinvar/RCV000043565/ 1 0 1
5 c.617 T > G p.Leu206Trp L206W CF causing Pathogenic *3 https://www.ncbi.nlm.nih.gov/clinvar/RCV000007611/ 2 0 2
6 c.1000 C > T p.Arg334Trp R334W CF causing Pathogenic *4 https://www.ncbi.nlm.nih.gov/clinvar/RCV000007559/ 1 0 1
7 c.1521_1523delCTT p.Phe508del F508del CF causing Pathogenic *4 https://www.ncbi.nlm.nih.gov/clinvar/RCV000007523/ 10 28 38
8 c.1624G > T p.Gly542Ter G542X CF causing Pathogenic *4 https://www.ncbi.nlm.nih.gov/clinvar/RCV000007535/ 1 0 1
9 c.1652G > A p.Gly551Asp G551D CF causing Pathogenic *4 https://www.ncbi.nlm.nih.gov/clinvar/RCV000007540/ 1 0 1
10 c.2128 A > T p.Lys710Ter K710X CF causing Pathogenic *3 https://www.ncbi.nlm.nih.gov/clinvar/RCV000007624/ 1 0 1
11 c.3705 T > G p.Ser1235Arg S1235R Non CF-causing Benign https://www.ncbi.nlm.nih.gov/clinvar/RCV000029527/ 1 0 1
12 c.3717 G > C p.Arg1239Ser R1239S NA NA NA 1 0 1
13 c.3718–2477 C > T NA NA CF causing Pathogenic *4 https://www.ncbi.nlm.nih.gov/clinvar/RCV000007586/ 1 0 1
14 c.4426 C > T p.Gln1476Ter Q1476X NA Pathogenic *2 https://www.ncbi.nlm.nih.gov/clinvar/RCV000047135/ 1 0 1
24 28 52

Variants #11 (S1235R) and #12 (R1239S) were identified in cases 23 and 22, respectively (see Table 1), in each case forming CFTR compound heterozygotes with F508del; however, neither variant was found as pathogenic variants in either the CFTR2 or ClinVar databases. Variant #14 was missed on clinical testing obtained in 2009 for case 26 (see Table 1). Note that only 42% (5/12) of the pathogenic variants in this table were included in the 2004 ACMG panel #3, 6, 7, 8, 9. The genomic screening used in this manuscript (WES plus microarray) is more sensitive than many of the clinical genetic tests offered in the past. aClinVar review status: *2 = endorsed by two or more submitters providing assertion criteria provided the same interpretation, *3 = endorsed by expert panel, *4 = endorsed by practice guideline